| IPO Listing At | BSE SME |
| SME IPO Issue Type | Fixed Price Issue |
| Total Issue Size | ₹15.21 Cr |
| Reserved for Market Maker | ₹0.00 Cr |
| Net Issue Size | ₹15.21 Cr |
| Fresh Issue | ₹14.43 Cr |
| Face Value | βΉ10 Per Equity Share |
| Issue Price | βΉ38.00 per share |
| Discount | Retail: 0.00 |
| BSE Code | 543594 |
| Registrar | Bigshare Services Pvt.Ltd. |
| Lead Managers | Interactive Financial Services Ltd. |
Disclaimer: GMP is sourced from grey market dealers and is indicative only. Always conduct your own due diligence.
* Allotment, Refund, Demat Credit & Listing dates are tentative and subject to change.
Minimum bid: 3,000 shares and in multiples thereof
Incorporated in 2011, Dipna Pharmachem Limited is engaged in theΒ trading and distribution of a wide range of pharmaceutical raw materialsΒ which is also known as APIs (Active Pharmaceutical Ingredients), Excipient and chemical formulation products. The Company also started selling chemicals on a commission basis in the Financial year 2022. The company conducts business in Ahmedabad and the surrounding area of Ahmedabad.
The company's product portfolio comprises 61 AIPs and AIPs intermediates such as Cephalosporins, Cardiovascular, Anti - Bacteria, Quinolones, Veterinary, Anti - Virus, Anti - Inflammatory, Neuropsychiatry, Steroid Hormone, other etc.
The company is supplying raw materials to pharmaceutical industries and the pharmaceutical industry falls under the essential business list declared by the Government.
Competitive Strengths :
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (βΉ Cr.) |
|---|---|---|
| 1 | Working capital requirement | 11.10 |
| 2 | General Corporate Purpose | 3.65 |
| Period Ended | 31 Mar 2022 | 31 Mar 2021 | 31 Mar 2020 |
|---|---|---|---|
| Assets | 36.23 | 24.79 | 18.44 |
| Total Income | 72.77 | 31.02 | 30.55 |
| Profit After Tax | 1.17 | 0.02 | 0.06 |
| NET Worth | 1.74 | 0.57 | 0.55 |
| Reserves and Surplus | 1.70 | 0.54 | 0.51 |
| Amount in ₹ Crore | |||
| KPI | |
|---|---|
| RoNW | 67.12% |
| Metric | Pre IPO | Post IPO |
|---|---|---|
| EPS (βΉ) | 333.40 | |
| P/E (x) | 39 | |
| Promoter Holding | 100% | 66.56% |
| Market Cap | βΉ45.49 Cr. | |